Institutional investors purchased a net $3.9 million shares of LIFE during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 49.80% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ECOR1 CAPITAL LLC Sold 725.5 Thousand shares of aTyr Pharma Inc